[b]$PLPL[/b] ~ The Magic Weight Loss Elixir
"Health Enhancement will be the largest health care industry in the 21st Century."
Dr James Canton, Ph.D. and world renown Global Futurist (globalfuturist.com)
What's the size of the market for weight loss products? According to MarketData, a leading independent research firm and it's 420 page study, it's $61 Billion- yes- that's Billion with a "B".
Adding to the frustration of the consumer is the lack of effective prescription medications that work. There are no blockbuster diet pills- none have shown they can be effective helping consumers lose more than 5% of body weight.
The key component for driving substantial sales in this arena and establishing credibility? -It's the Clinical Trial. The big consumers in this area want to see the proof. The Whole Foods of the world want the data. The beverage manufacturers that might include Phytophare in their offering want evidence. Distributors want to make claims they are selling something better.
Plandai's Green Tea Extract- trade marked Phytofare by the company, is getting ready to dive into its first formal clinical trial. The company is convinced they have a virtual miracle health product, and are planning to prove it.
In about a month 90 humans will start ingesting Phytofare. Some will get a placebo. The study is being managed by an independent firm. Full blood panels, weight, and changes in body fat and mood will be measured.
In the end, Plandai (PLPL) expects to prove Phytofare effectively enhances weight loss, reduces hypertension, reduces cholesterol.
Many have tried this and failed. Why Plandai (PLPL)? I can be summed up in one word- Bioavailability.
Most products are 2% to 13% Bioavailble. Another words, when you ingest the stuff, only 2% to 13% ends up finding its way into your blood stream.
Because Phytophare is so concentrated thanks to PLPL's proprietary and patented extraction process, a cup of their stuff is equivalent to a gallon of everyone else's, and it's proven to be substantially more bioavailable than any other product.
Clinical results drive stock prices in the biotech world. Witness what happened with OTC Journal featured stock Inovio (INO) - $.67 to $3 in 3 months. Back at $1.50, we'll be looking at it again.
Technically, PLPL looks as if it could start heading north again any day now.
As you can see, the first four months of 2013 were extremely good for PLPL shareholders. This little stock moved up 5 fold from under $.10 to $.50. Share buyers clearly believe they have something. special.
From early May PLPL has been trading sideways on lighter volumes. This is called a "basing period". a 3 1/2 month base is pretty long. The longer the base, the bigger the move when it starts.
This 3 1/2 months has given anyone who wanted out ample opportunity to do so.
PLPL is getting ready to start growing and harvesting its green tea in South Africa. It can grow and harvest a fuill crop every month.
They have signed a number of global distribution agreements for Phytophare, so as soon as its extracted and available, sales will commence.
Note the company's timing- the studies will be published in conjunction with the product roll out.
If this becomes the de Facto choice in the neutracueticals sector, there's no limit to how high PLPL can head. It's likely headed to about $1 to start its next base.
Now you know why this stock solidly camped above its 200 DMA (red), and right on its 50 DMA (blue). It's in a long term and short term up trend, and the next volume surge should start a renewed climb.
$1 for its next base, but the right trial results, and we could be looking at hundreds of millions in sales. There's your real, long term upside.
